comparemela.com

Latest Breaking News On - European medical cannabis - Page 2 : comparemela.com

Jazz Pharmaceuticals will acquire CBD drugmaker GW Pharma for $7 2 billion

Close icon Two crossed lines that form an X . It indicates a way to close an interaction, or dismiss a notification. Cannabidiol, or CBD, is an active compound found in cannabis plants. Pramote Polyamate/ Getty Image Jazz Pharmaceuticals is buying drugmaker GW Pharma in a blockbuster $7.2 billion deal. Jazz is paying a 50% premium for GW, a signal of the biotech s bullishness on cannabis-based treatments. GW produces Epidiolex, an epilepsy drug derived from cannabis. It s the only FDA-approved drug containing CBD. Jazz Pharmaceuticals is making a $7.2 billion bet on the future of medical cannabis.  The drugmaker said on Wednesday it will acquire GW Pharma, the maker of CBD-based epilepsy treatment Epidiolex, in a cash-and-stock deal. It s the largest cannabis-industry deal so far. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.